MARCHF2 and systemic lupus erythematosus: Consistently, MARCH2 mRNA levels were significantly lower in patients with SLE than in healthy donors (Figure 8Q), supporting the hypothesis that dysregulated TFEB and MARCH2 contribute to PBLD upregulation in SLE.